Thrivent Financial for Lutherans’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-195,402
| Closed | -$23.6M | – | 2565 |
|
|
2023
Q1 | $23.6M | Buy |
195,402
+3,162
| +2% | +$381K | 0.06% | 382 |
|
|
2022
Q4 | $22.1M | Buy |
192,240
+24,100
| +14% | +$2.77M | 0.06% | 391 |
|
|
2022
Q3 | $17.2M | Buy |
168,140
+26,545
| +19% | +$2.72M | 0.05% | 433 |
|
|
2022
Q2 | $14.4M | Buy |
141,595
+7,385
| +6% | +$750K | 0.04% | 489 |
|
|
2022
Q1 | $15.6M | Buy |
134,210
+8,500
| +7% | +$989K | 0.03% | 546 |
|
|
2021
Q4 | $14.4M | Buy |
+125,710
| New | +$14.4M | 0.03% | 565 |
|
|
2020
Q4 | – | Sell |
-88,000
| Closed | -$9.85M | – | 2513 |
|
|
2020
Q3 | $9.85M | Hold |
88,000
| – | – | 0.03% | 603 |
|
|
2020
Q2 | $9.21M | Buy |
+88,000
| New | +$9.21M | 0.03% | 567 |
|